[go: up one dir, main page]

HK40095492A - Combination therapy for treating abnormal cell growth - Google Patents

Combination therapy for treating abnormal cell growth Download PDF

Info

Publication number
HK40095492A
HK40095492A HK62023082555.1A HK62023082555A HK40095492A HK 40095492 A HK40095492 A HK 40095492A HK 62023082555 A HK62023082555 A HK 62023082555A HK 40095492 A HK40095492 A HK 40095492A
Authority
HK
Hong Kong
Prior art keywords
cell growth
combination therapy
abnormal cell
treating abnormal
treating
Prior art date
Application number
HK62023082555.1A
Other languages
Chinese (zh)
Inventor
Silvia COMA
Jonathan A. Pachter
Original Assignee
Verastem, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verastem, Inc. filed Critical Verastem, Inc.
Publication of HK40095492A publication Critical patent/HK40095492A/en

Links

HK62023082555.1A 2020-07-13 2021-07-13 Combination therapy for treating abnormal cell growth HK40095492A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063051320P 2020-07-13

Publications (1)

Publication Number Publication Date
HK40095492A true HK40095492A (en) 2024-02-02

Family

ID=

Similar Documents

Publication Publication Date Title
EP4096671A4 (en) Combination therapy for treating abnormal cell growth
EP4376828A4 (en) Combination therapy for treating abnormal cell growth
EP4076479A4 (en) Engineered cells for therapy
AU2022205653A9 (en) T cell therapy
IL305861A (en) Treatment for sickle cell anaemia
HK40112304A (en) Combination therapy for treating abnormal cell growth
HK40107678A (en) Combination therapy for treating abnormal cell growth
HK40103638A (en) Combination therapy for treating abnormal cell growth
HK40095492A (en) Combination therapy for treating abnormal cell growth
HK40078478A (en) Combination therapy for treating abnormal cell growth
EP4046636A4 (en) Composition for treating spinal cord injury, comprising stem cells treated with novel compound
GB202212144D0 (en) Cells for therapy
HK40116577A (en) Methods of treating abnormal cell growth
HK40089147A (en) Methods of treating abnormal cell growth
HK40106614A (en) Method for treating cells
HK40114477A (en) Bcma-targeted car-t cell therapy for multiple myeloma
HK40106447A (en) Treatment for sickle cell anaemia
HK40101802A (en) Bcma-targeted car-t cell therapy for multiple myeloma
HK40107501A (en) Gene therapy for treating beta-hemoglobinopathies
HK40114988A (en) Bcma-targeted car-t cell therapy for multiple myeloma
HK40089794A (en) Methods for treating covid-19
AU2025902791A0 (en) Methods for treatment
AU2025901074A0 (en) Methods for treatment
AU2020900675A0 (en) Combination Treatment for Microorganisms
HK40104134A (en) T cell therapy